GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp III (NAS:ARYA) » Definitions » YoY EBITDA Growth

ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) YoY EBITDA Growth : 0.00% (As of Mar. 2021)


View and export this data going back to 2020. Start your Free Trial

What is ARYA Sciences Acquisition III YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. ARYA Sciences Acquisition III's YoY EBITDA Growth for the quarter that ended in Mar. 2021 was 0.00%.

ARYA Sciences Acquisition III's EBITDA per Share for the three months ended in Mar. 2021 was $-0.09.

ARYA Sciences Acquisition III YoY EBITDA Growth Historical Data

The historical data trend for ARYA Sciences Acquisition III's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ARYA Sciences Acquisition III YoY EBITDA Growth Chart

ARYA Sciences Acquisition III Annual Data
Trend Dec20
YoY EBITDA Growth
-

ARYA Sciences Acquisition III Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21
YoY EBITDA Growth - - - - -

ARYA Sciences Acquisition III YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

ARYA Sciences Acquisition III's YoY EBITDA Growth for the fiscal year that ended in Dec. 2020 is calculated as:

YoY EBITDA Growth (A: Dec. 2020 )
=(EBITDA per Share (A: Dec. 2020 )-EBITDA per Share (A: . 20 ))/ | EBITDA per Share (A: . 20 ) |
=(-)/ | |
=N/A %

ARYA Sciences Acquisition III's YoY EBITDA Growth for the quarter that ended in Mar. 2021 is calculated as:

YoY EBITDA Growth (Q: Mar. 2021 )
=(EBITDA per Share (Q: Mar. 2021 )-EBITDA per Share (Q: Mar. 2020 )) / | EBITDA per Share (Q: Mar. 2020 )) |
=(-0.093-0)/ | 0 |
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ARYA Sciences Acquisition III YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of ARYA Sciences Acquisition III's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

ARYA Sciences Acquisition III (ARYA Sciences Acquisition III) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » ARYA Sciences Acquisition Corp III (NAS:ARYA) » Definitions » YoY EBITDA Growth
Comparable Companies
Traded in Other Exchanges
N/A
Address
51 Astor Place, 10th Floor, New York, NY, USA, 10003
Website
ARYA Sciences Acquisition Corp III is a blank check company.
Executives
Adam Leo Stone director, 10 percent owner, officer: Chief Executive Officer C/O SOLID BIOSCIENCES, LLC, 141 PORTLAND STREET, FIFTH FLOOR, CAMBRIDGE MA 02139
Michael Seth Altman director, 10 percent owner, officer: Chief Financial Officer C/O PERCEPTIVE ADVISORS, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Arya Sciences Holdings Iii 10 percent owner 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Saqib Islam director ALEXION PHARMACEUTICALS, 352 KNOTTER DRIVE, CHESHIRE CT 06410
Joseph Edelman director C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Todd Wider director 4848 LEMMON AVENUE, SUITE 517, DALLAS TX 75219
Bradley L Campbell director C/O AMICUS THERAPEUTICS, INC., 1 CEDAR BROOK DRIVE, CRANBURY NJ 08512
Konstantin Poukalov officer: Chief Business Officer C/O KADMON HOLDINGS, LLC, 450 E 29TH STREET, NEW YORK NY 10016